cancer

This article is the sixth in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Nearly 1.7 million Americans were diagnosed with cancer last year. National expenditures for care are estimated to rise to $156 billion in 2020. Cancer is the second leading cause of death in the United States, claiming more than half-a-million lives each year. Joseph R. Biden, Jr., 47 th Vice President of the United States, is leading efforts to accelerate the pace of cancer research through collaboration and innovative partnerships, and has been hailed as the driving...
This article is the fourth in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Nobel laureate Phillip A. Sharp, Ph.D., is Research!America’s recipient of the Raymond and Beverly Sackler Award for Sustained National Leadership , which honors medical and health research advocacy leaders who have been instrumental in developing and implementing a sustained advocacy program for medical and health research. Prof. Sharp is an Institute Professor at the Massachusetts Institute of Technology and serves as Chair of Stand Up To Cancer’s (SU2C) Scientific...
Ahead of World Cancer Day on February 4, the American Association for Cancer Research (AACR) would like to thank the thousands of laboratory researchers, physician-scientists, healthcare professionals and patient advocates around the globe and recognize their commitment to increasing the number of cancer survivors who are alive today. In the U.S., thanks to decades of federally funded cancer research supported by the National Institutes of Health (NIH) and the National Cancer Institute (NCI), we have seen a steady rise in the number of Americans who survive a cancer diagnosis. Our continued commitment to preventing and curing cancer comes at a time when, despite all the incredible progress...
As World Cancer Day approaches, Moffitt Cancer Center remains committed to supporting research that addresses the health care needs of LGBTQ patients who are at-risk or suffering from cancer. The lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) community, also referred to as sexual and gender minorities (SGMs), is a growing and medically underserved population in the United States. It spans all races, ethnicities, ages, socioeconomic statuses, and regions of the United States and accounts for roughly 3% to 12% of the adult population. LGBTQ individuals have higher disease risk and worse health outcomes for many diseases than heterosexual and cisgender (having a gender...
Gregg Gordon was 44 and the picture of health until he suddenly became excessively tired and noticed two small bumps on his shin. A visit to his doctor led to a startling cancer diagnosis, and less than 24 hours later he was receiving chemotherapy to treat acute myeloid leukemia. When standard treatments failed, Gregg’s best hope was a bone marrow transplant, but he could not find a donor match. Fortunately, he was referred to Colleen Delaney, M.D., in Seattle, who had developed a process for expanding stem cells from umbilical cord blood for use in patients without donors. As The Washington Post reported in September 2016, the procedure was a success and Gregg has been cancer-free for five...
In the U.S., it is estimated that 1 in 2 men and 1 in 3 women will develop cancer in their lifetime even though 50% of cancer deaths are preventable. The Bipartisan Policy Center (BPC) and the American Cancer Society Cancer Action Network hosted a panel on Friday, September 30 in Washington, D.C. on the future of cancer prevention with top public health experts. “We cannot achieve the full potential in our cancer fight unless we embrace and implement everything we have learned about prevention,” said Dr. Richard Wender, the American Cancer Society’s Chief Cancer Control Officer, and keynote speaker. Of the 26% decline in cancer death rates among women in the United States from 1930-2012, he...
The American Association for Cancer Research (AACR) has released the annual Cancer Progress Report , highlighting advances in cancer research, as well as advocating for sustained and robust funding for federal health agencies. AACR also hosted a congressional briefing on the progress report on Wednesday, September 21 to bring to Congress’ attention the importance of funding for research and emphasized patient involvement in moving research forward. Patient participation in clinical trials is important not only to test the efficacy of cancer drugs, but also to further the precision medicine initiative that aims to individualize cancer treatment based on each patient’s genetic code and...
Cancer researchers hope support for the Cancer Moonshot will speed the pace of discovery of life-saving technologies. Speakers at a Capitol Hill briefing held Thursday, September 15, agreed that the moonshot could heighten awareness of the importance of sustained federal funding for cancer research. The briefing, hosted by the American Institute for Medical and Biological Engineering, focused on advances in cancer research that hope to someday replace current treatments such as radiation and chemotherapy. As a result of current therapies, cancer has on average seen a decline in incidence and mortality. However, this is not true of all cancers, said Dr. Krishna Kandarpa, director of research...
Dear Research Advocate: Vice President Joe Biden continued the drumbeat for the Cancer Moonshot with a visit to Research!America member Johns Hopkins University on Tuesday. He spoke about the critical importance of the private sector in the discovery, development, delivery ecosystem. Indeed, from public-private partnerships to philanthropic donations, the private sector is an essential partner in the fight against deadly and debilitating diseases. Demonstrating both this point and his personal commitment to research, former New York Mayor --and Research!America Advocacy Award recipient-- Michael Bloomberg joined Sidney Kimmel and others in announcing a $125 million donation to create the...
More than 1.6 million people developed cancer in the U.S. in 2015, and 1 in 2 men and 1 in 3 women will be diagnosed with cancer over the course of their lives. Cancer also has a major fiscal impact: the economic burden totaled $263.8 billion in 2013, translating to nearly $900 per American. On March 10, 2016, Research!America, in partnership with AcademyHealth, American Cancer Society, and Celgene Corporation convened a panel of cancer experts to discuss how research is working to stop cancer. Dr. Lisa Simpson, president and CEO of AcademyHealth, started the conversation by outlining cancer innovation as a continuum. Basic research provides answers on how living organisms work and what...

Pages

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America